GLSI Stock: Greenwich LifeSciences, Inc. Stock Price, Analysis & Insights
Get live glsi stock price $17.21, comprehensive Greenwich LifeSciences, Inc. stock analysis, charts, news, and expert forecast. Real-time glsi stock data and investment insights.
Loading chart...
Company Overview
Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who have previously undergone surgery. The company was formerly known as Norwell, Inc. and changed its name to Greenwich LifeSciences, Inc. in March 2018. Greenwich LifeSciences, Inc. was incorporated in 2006 and is headquartered in Stafford, Texas.
Company Information
- CEO
- Snehal S. Patel
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 4
Contact Information
- Address
- Building 14
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Higher growth potential with elevated volatility (Beta: 2.92)
Business Model & Strategy
Greenwich LifeSciences, Inc. operates in the Biotechnology industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Snehal S. Patel, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Biotechnology model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
Greenwich LifeSciences, Inc. competes in the Biotechnology within the broader Healthcare. With 238.2 million in market capitalization, the company is positioned as a emerging competitor in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the NASDAQ Capital Market, Greenwich LifeSciences, Inc. provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating Greenwich LifeSciences, Inc. should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Greenwich LifeSciences, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Greenwich LifeSciences, Inc.
- ⚠Investors should consider how Greenwich LifeSciences, Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
238.25M
P/E Ratio
-11.79
Beta
2.92
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 238.25M market capitalization
- Trading Volume: 465.09K shares traded today
- Price Range: 52-week range of $7.78 - $17.99
- Exchange: Listed on NASDAQ Capital Market
Financial Metrics
Market Analysis for Greenwich LifeSciences, Inc.
Greenwich LifeSciences, Inc. (GLSI) operates in the Biotechnology industry within the Healthcare sector. With a current market capitalization of 238.25M, the company represents a significant player in its market. The stock is currently trading at $17.21 with a positivedaily change of 18.12%.
The company's 4 employee base and presence on the NASDAQ Capital Marketexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -11.79, beta of 2.92, and 52-week price range from $7.78 to $17.99when evaluating investment opportunities.
Why Invest in Greenwich LifeSciences, Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (NASDAQ Capital Market)
- • Experienced leadership under Snehal S. Patel
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.